/INGN
INGN Stock - Inogen, Inc.
Healthcare|Medical - DevicesNASDAQ
$6.22+0.16%
+$0.01 (+0.16%) • Jan 13
59
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.15
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).100
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.49
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+318.0%upside
Target: $26.00
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for INGN
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$6.16 – $6.28
TARGET (TP)$26.00
STOP LOSS$5.72
RISK/REWARD1:39.6
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.77
52W High$12.91
52W Low$5.70
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $335.70M | $315.66M | $377.24M | $358.00M | $308.49M |
| Gross Profit | $154.74M | $126.70M | $153.53M | $176.48M | $138.18M |
| Gross Margin | 46.1% | 40.1% | 40.7% | 49.3% | 44.8% |
| Operating Income | $-42,516,000 | $-109,386,000 | $-85,243,000 | $9.24M | $-12,025,000 |
| Net Income | $-35,888,000 | $-102,449,000 | $-83,772,000 | $-6,333,000 | $-5,829,000 |
| Net Margin | -10.7% | -32.5% | -22.2% | -1.8% | -1.9% |
| EPS | $-1.52 | $-4.42 | $-3.67 | $-0.28 | $-0.27 |
Company Overview
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Inogen Tidal Assist Ventilators, as well as related accessories. The company also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.
Visit WebsiteRating Distribution
Strong Buy
0%
Buy / Outperform
3
60%
Hold / Neutral
2
40%
Sell / Underperform
0%
Analyst Consensus🟡 Mixed
3 Bullish2 Neutral/Bearish
Price Targets
$11
Average Target
↑ 82.2% Upside
Now
$8
Low
$11
Average
$14
High
Based on 3 analysts
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| June 16th 2025 | B. Riley Securities | Initiation | Buy | $14 |
| May 22nd 2025 | Needham | Upgrade | Buy | $12 |
| February 15th 2024 | William Blair | Upgrade | Outperform | - |
| August 8th 2023 | JP Morgan | Downgrade | Neutral | $8← $15 |
| July 14th 2023 | Needham | Downgrade | Hold | - |
| January 17th 2023 | William Blair | Downgrade | Market Perform | - |
Earnings History & Surprises
INGNBeat Rate
83%
Last 18 quarters
Avg Surprise
+39.1%
EPS vs Estimate
Beats / Misses
15/3
Last 12 quarters
Latest EPS
$-0.20
Q4 2025
EPS Surprise History
Q1 24
-83.9%
$-1.14vs$-0.62
Q2 24
+18.4%
$-0.62vs$-0.76
Q3 24
+56.4%
$-0.24vs$-0.55
Q4 24
+49.0%
$-0.25vs$-0.49
Q1 25
+26.8%
$-0.41vs$-0.56
Q2 25
+51.9%
$-0.25vs$-0.52
Q3 25
+31.8%
$-0.15vs$-0.22
Q4 25
+9.1%
$-0.20vs$-0.22
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 5, 2026 | — | — | — | — |
Q1 2026 | Feb 24, 2026 | $-0.31 | — | — | — |
Q4 2025 | Nov 5, 2025 | $-0.22 | $-0.20 | +9.1% | ✓ BEAT |
Q3 2025 | Aug 7, 2025 | $-0.22 | $-0.15 | +31.8% | ✓ BEAT |
Q2 2025 | May 7, 2025 | $-0.52 | $-0.25 | +51.9% | ✓ BEAT |
Q1 2025 | Feb 25, 2025 | $-0.56 | $-0.41 | +26.8% | ✓ BEAT |
Q4 2024 | Nov 7, 2024 | $-0.49 | $-0.25 | +49.0% | ✓ BEAT |
Q3 2024 | Aug 6, 2024 | $-0.55 | $-0.24 | +56.4% | ✓ BEAT |
Q2 2024 | May 7, 2024 | $-0.76 | $-0.62 | +18.4% | ✓ BEAT |
Q1 2024 | Feb 27, 2024 | $-0.62 | $-1.14 | -83.9% | ✗ MISS |
Q4 2023 | Nov 7, 2023 | $-0.57 | $-1.97 | -245.6% | ✗ MISS |
Q3 2023 | Aug 7, 2023 | $-0.59 | $-0.42 | +28.8% | ✓ BEAT |
Q2 2023 | May 4, 2023 | $-0.77 | $-0.63 | +18.2% | ✓ BEAT |
Q1 2023 | Feb 23, 2023 | $-0.60 | $-0.57 | +5.0% | ✓ BEAT |
Q4 2022 | Nov 2, 2022 | $-0.41 | $-0.18 | +56.1% | ✓ BEAT |
Q3 2022 | Aug 4, 2022 | $-0.40 | $-0.02 | +95.0% | ✓ BEAT |
Q2 2022 | May 5, 2022 | $-0.48 | $-0.38 | +20.8% | ✓ BEAT |
Q1 2022 | Feb 24, 2022 | $-0.73 | $-1.01 | -38.4% | ✗ MISS |
Q4 2021 | Nov 4, 2021 | $-0.26 | $0.53 | +303.8% | ✓ BEAT |
Q3 2021 | Aug 4, 2021 | $-0.11 | $0.22 | +300.0% | ✓ BEAT |
Latest News
Inogen shares are trading lower after the company lowered its Q4 and FY25 sales guidance.
📉 NegativeBenzinga•Jan 12, 2026, 05:09 PM
Inogen Estimates Preliminary Total Revenue In Q4 To Be ~$82M, Up ~2% YoY; Expects FY25 Preliminary Revenue To Be ~$349M, Up ~4% YoY
📈 PositiveBenzinga•Jan 12, 2026, 01:38 PM
Inogen Lowers Q4 Sales Guidance from $87.000M-$90.000M to $82.000M vs $88.600M Est
📉 NegativeBenzinga•Jan 12, 2026, 01:34 PM
Inogen Lowers FY2025 Sales Guidance from $354.000M-$357.000M to $349.000M vs $355.600M Est
📉 NegativeBenzinga•Jan 12, 2026, 01:34 PM
Inogen shares are trading higher after the company launched its Aurora CPAP masks in the US.
📈 PositiveBenzinga•Jan 7, 2026, 01:33 PM
Inogen Launches Aurora CPAP Masks In The US
📈 PositiveBenzinga•Jan 7, 2026, 01:33 PM
Inogen Sees Q4 Sales $87.000M-$90.000M vs $89.050M Est
➖ NeutralBenzinga•Nov 5, 2025, 12:34 PM
Inogen Affirms FY2025 Sales Guidance of $354.000M-$357.000M vs $355.850M Est
➖ NeutralBenzinga•Nov 5, 2025, 12:33 PM
Inogen Q3 Adj. EPS $(0.02) Beats $(0.22) Estimate, Sales $92.390M Beat $92.200M Estimate
📈 PositiveBenzinga•Nov 5, 2025, 12:31 PM
Frequently Asked Questions about INGN
What is INGN's current stock price?
Inogen, Inc. (INGN) is currently trading at $6.22 per share. The stock has moved +0.16% today.
What is the analyst price target for INGN?
The average analyst price target for INGN is $26.00, based on 1 analyst.
What sector is Inogen, Inc. in?
Inogen, Inc. operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the NASDAQ exchange.
What is INGN's market cap?
Inogen, Inc. has a market capitalization of $0.17 billion, making it a small-cap company.
Does INGN pay dividends?
No, Inogen, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorCATX
Perspective Therapeutics, Inc.
$2.51
Mkt Cap: $0.2B
EPRX
Eupraxia Pharmaceuticals Inc.
$8.31
Mkt Cap: $0.3B
HCAT
Health Catalyst, Inc.
$2.40
Mkt Cap: $0.2B
HSDT
Solana Company
$3.45
Mkt Cap: $0.1B
NNOX
Nano-X Imaging Ltd.
$3.04
Mkt Cap: $0.2B
OM
Outset Medical, Inc.
$5.12
Mkt Cap: $0.1B
QTRX
Quanterix Corporation
$7.16
Mkt Cap: $0.3B
SGHT
Sight Sciences, Inc.
$6.83
Mkt Cap: $0.4B
SI
SHOULDER INNOVATIONS, INC.
$13.60
Mkt Cap: $0.3B
SNWV
SANUWAVE Health, Inc.
$28.57
Mkt Cap: $0.2B
Explore stocks similar to INGN for comparison